Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
FDA Approval Isn't Always a Happy Day for Biotech Investors
Business

FDA's OK Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

FDA Approval Isn't Always a Happy Day for Biotech Investors
Finances

FDA Approval Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts
Business

Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts

Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss drug and another medicine in

Obesity Drugs Won't Starve These Other Potential Blockbusters
Finances

Obesity Drugs Won't Starve These Other Potential Blockbusters

Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link

Mallinckrodt in Talks to Cut Opioid Settlement by Up to $1 Billion
Business

Mallinckrodt in Talks to Cut Opioid Settlement by Up to $1 Billion

Mallinckrodt, the financially troubled pharmaceutical company, is in discussions with a compensation trust for opioid victims as it seeks to potentially reduce the amount of

FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
Business

FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients

Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link

Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook
Business

Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook

First-quarter earnings were largely wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments. Source link

Demand for Obesity Drugs Has Insurers Paying Close Attention
Finances

Demand for Obesity Drugs Has Insurers Paying Close Attention

Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link

Moderna, Merck Show Progress Toward Cancer Vaccines
Business

Moderna, Merck Show Progress Toward Cancer Vaccines

An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link

WeightWatchers Gets a Makeover With Obesity-Drug Business
Finances

WeightWatchers Gets a Makeover With Obesity-Drug Business

Markets Heard on the Street The decision to get into the business for drugs such as Ozempic makes sense Source link